Evidence map›Paper›PMID 26729373›Full record

ArticleBMC genomics2016

Improved transcription and translation with L-leucine stimulation of mTORC1 in Roberts syndrome.

Baoshan Xu, Madelaine Gogol, Karin Gaudenz, Jennifer L Gerton

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. GWIPS-viz: 2018 update.Nucleic acids research · 2018
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Baoshan XuStowers Institute for Medical Research, 1000 E 50th St, Kansas City, MO, 64110, USA. bax@stowers.org.
Madelaine GogolStowers Institute for Medical Research, 1000 E 50th St, Kansas City, MO, 64110, USA. mcm@stowers.org.
Karin GaudenzStowers Institute for Medical Research, 1000 E 50th St, Kansas City, MO, 64110, USA. kzg@stowers.org.
Jennifer L GertonStowers Institute for Medical Research, 1000 E 50th St, Kansas City, MO, 64110, USA. jeg@stowers.org.
Stowers Institute for Medical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRoberts syndrome (RBS) is a human developmental disorder caused by mutations in the cohesin acetyltransferase ESCO2. We previously reported that mTORC1 signaling was depressed and overall translation was reduced in RBS cells and zebrafish models for RBS. Treatment of RBS cells and zebrafish RBS models with L-leucine partially rescued mTOR function and protein synthesis, correlating with increased cell division and improved development.

resultsIn this study, we use RBS cells to model mTORC1 repression and analyze transcription and translation with ribosome profiling to determine gene-level effects of L-leucine. L-leucine treatment partially rescued translational efficiency of ribosomal subunits, translation initiation factors, snoRNA production, and mitochondrial function in RBS cells, consistent with these processes being mTORC1 controlled. In contrast, other genes are differentially expressed independent of L-leucine treatment, including imprinted genes such as H19 and GTL2, miRNAs regulated by GTL2, HOX genes, and genes in nucleolar associated domains.

conclusionsOur study distinguishes between gene expression changes in RBS cells that are TOR dependent and those that are independent. Some of the TOR independent gene expression changes likely reflect the architectural role of cohesin in chromatin looping and gene expression. This study reveals the dramatic rescue effects of L-leucine stimulation of mTORC1 in RBS cells and supports that normal gene expression and translation requires ESCO2 function.

Indexed as

Transcription, GeneticAcetyltransferasesAnimalsChromosomal Proteins, Non-HistoneCraniofacial AbnormalitiesDisease Models, AnimalEctromeliaHumansHypertelorismLeucineMutationProtein BiosynthesisRibosomesTOR Serine-Threonine KinasesZebrafishAcetyltransferasesChromosomal Proteins, Non-HistoneESCO2 protein, humanLeucineMTOR protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID26729373
PMCPMC4700579
OpenAlexW2231493848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.